Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 401 | PSNL | PERSONALIS INC | Healthcare | 14,471.0 | $115K | 0.01% | -1K | -6.9% | $7.96 | -0.1% |
| 402 | ZLAB | ZAI LAB LTD-ADR | Healthcare | 6,380.0 | $113K | 0.01% | -2K | -23.9% | $17.64 | +6.6% |
| 403 | IVVD | INVIVYD INC | Healthcare | 45,157.0 | $112K | 0.01% | NEW | — | $2.47 | -55.1% |
| 404 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 3,457.0 | $106K | 0.01% | +90.0 | +2.7% | $30.78 | -43.8% |
| 405 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 15,353.0 | $106K | 0.01% | -723.0 | -4.5% | $6.90 | +68.0% |
| 406 | ATEC | ALPHATEC HOLDINGS INC | Healthcare | 5,000.0 | $105K | 0.01% | — | — | $21.04 | -60.9% |
| 407 | MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | 13,116.0 | $104K | 0.01% | -985.0 | -7.0% | $7.95 | +19.4% |
| 408 | IMRX | IMMUNEERING CORP - CLASS A | Healthcare | 15,522.0 | $102K | 0.01% | +11K | +210.4% | $6.58 | -20.7% |
| 409 | PRME | PRIME MEDICINE INC | Healthcare | 29,414.0 | $102K | 0.01% | -1K | -4.0% | $3.47 | -18.4% |
| 410 | KROS | KEROS THERAPEUTICS INC | Healthcare | 4,964.0 | $101K | 0.01% | -2K | -30.3% | $20.36 | -44.9% |
| 411 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 8,819.0 | $100K | 0.01% | NEW | — | $11.31 | -41.7% |
| 412 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 9,626.0 | $100K | 0.01% | -729.0 | -7.0% | $10.35 | +35.1% |
| 413 | AXGN | AXOGEN INC | Healthcare | 3,000.0 | $98K | 0.01% | NEW | — | $32.73 | +26.2% |
| 414 | PACB | PACIFIC BIOSCIENCES OF CALIF | Healthcare | 49,196.0 | $92K | 0.01% | -3K | -6.6% | $1.87 | -33.2% |
| 415 | — | BIOHAVEN LTD | — | 8,000.0 | $90K | 0.01% | -12K | -60.0% | $11.29 | — |
| 416 | IRWD | IRONWOOD PHARMACEUTICALS INC | Healthcare | 26,508.0 | $89K | 0.01% | -2K | -6.9% | $3.37 | +14.2% |
| 417 | VNDA | VANDA PHARMACEUTICALS INC | Healthcare | 9,630.0 | $85K | 0.01% | -727.0 | -7.0% | $8.82 | -29.9% |
| 418 | PRTA | PROTHENA CORP PLC | Healthcare | 8,772.0 | $84K | 0.01% | -664.0 | -7.0% | $9.55 | -2.1% |
| 419 | SLN | SILENCE THERAPEUTICS PLC-ADR | Healthcare | 13,653.0 | $83K | 0.01% | +5K | +65.8% | $6.08 | +2.6% |
| 420 | — | ZEVRA THERAPEUTICS INC | — | 9,174.0 | $82K | 0.01% | -666.0 | -6.8% | $8.96 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
39.5%
Healthcare
21.2%
Communication Services
12.4%
Financial Services
10.6%
Consumer Cyclical
10.1%
Consumer Defensive
2.7%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%